News

Older individuals who self-reported using psychedelics had fewer depressive symptoms and higher cognitive performance, a new study, published in Gerontology and Geriatric Medicine, has found.

People with an irregular heart rhythm taking a common blood pressure drug may be at greater risk of serious bleeding, according to a study.

Older people with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet.

Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML).

ASU researchers uncovered new insights into the main human cold and menthol sensor TRPM8 (transient receptor potential melastatin 8), offering hope for future nonaddictive pain therapies.

For the first time scientists managed to generate kidney organoids with a complex vascular system. These are asembloids, micrometric organoids formed by the union of kidney organoids with vascular organoids in 3D.

Biomedical engineers at Duke University have developed a new technique to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B (LGMD2B).

Scripps Research scientists found that a “one-two punch” of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some cancers, including Hodgkin lymphoma.

Targeting senescent cells with rejuvenation therapies may be detrimental, as these cells play key roles in normal physiology.

Combining a microbe and a prebiotic encourages the production of an important metabolite for gut health, stifling allergic responses to cow's milk, reveals new study.